ICU Medical (ICUI) Tops Q4 EPS by 36c; offers guidance

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.57, $0.36 better than the analyst estimate of $1.21. Revenue for the quarter came in at $587.86 million versus the consensus estimate of $561.9 million.

GUIDANCE:

ICU Medical sees FY2024 EPS of $4.40-$5.10, versus the consensus of $5.18.

Expects adjusted EBITDA to be in the range of $330 million to $370 million

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Kroger meets earnings expectations, revenue tops estimates
• SpaceX receives Baa1 rating from Moody's with stable outlook